Vimarsana
Biggest News Aggregation in the World

Page 4 - Venus Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Venus Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Venus Medtech Today - Breaking & Trending Today

Qiming Venture Partners Nisa Leung and Duane Kuang Made the 2023 Forbes Midas List - Vimarsana News

Qiming Venture Partners Nisa Leung and Duane Kuang Made the 2023 Forbes Midas List

SHANGHAI, May 5, 2023 /PRNewswire/ -- The 2023 Forbes Midas List, a prestigious industry list of world's best venture capital investors, was unveiled. Qiming Venture Partners Managing Partner

Qiming Venture Partners' portfolio company MedSci successfully listed on HKEX main board - Vimarsana News

Qiming Venture Partners' portfolio company MedSci successfully listed on HKEX main board

/PRNewswire/ -- On April 27th Beijing time, Qiming Venture Partners' portfolio company MedSci Healthcare Holdings Limited("MedSci"), a leading physician...

Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq - Vimarsana News

Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq

SHANGHAI, March 31, 2023 /PRNewswire/ -- On March 30, 2023, Apollomics Inc. ("Apollomics"), an innovative biopharmaceutical company and portfolio company of Qiming Venture Partners, listed on

Confirmatory clinical trial of Liwen RF™ ablation system in China concluded - Vimarsana News

Confirmatory clinical trial of Liwen RF™ ablation system in China concluded

/PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the...

Venus Medtech (Hangzhou) Inc.: Confirmatory clinical trial of Liwen RF ablation system in China concluded - Vimarsana News

Venus Medtech (Hangzhou) Inc.: Confirmatory clinical trial of Liwen RF ablation system in China concluded

HANGZHOU, China, March 4, 2023 /PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen